Myeloma and Related Diseases Registry

Helping clinicians and hospitals to provide the best possible care to people with multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasma cell leukaemia or plasmacytoma.

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works, data we collect and what we do with it.
Benefits

Participation in the registry provides advantages for sites and patients.
How to participate

Are you interested in getting involved? Find out more about registry participation, and registry projects and publications.
3204

Patients accrued

2055

Patients with multiple myeloma

41

Number of approved sites

362

Biobank participants

Latest news

MRDR at Blood 2019 conference
23 Oct 2019

The MRDR was well represented at the Blood 2019 conference in Perth in October with multiple oral presentations, the MRDR interest group breakfast and presence at the Monash University booth.

Read more
MRDR at the International Myeloma Workshop
10 Sep 2019

The MRDR had a busy and productive meeting at the IMW in Boston, USA.

Read more
3000 registered!!!
22 Aug 2019

The MRDR reached 3000 patients registered on August 22.

Read more
New MRDR publication!
01 Aug 2019

An MRDR paper by Prof Joy Ho was recently published in the journal “Clinical Lymphoma, Myeloma and Leukemia”.

Read more

Participating organisations